ArticleIrish journal of medical science2026
Evaluation of the modified early warning score (MEWS) and triage early warning score (TREWS) for prognostic assessment of hospitalized COVID-19 patients in a tertiary care hospital.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmid the overcrowding of healthcare services in Brazil, the early identification of critically ill COVID-19 patients becomes essential.
aimsThis study aims to evaluate the ability of the Modified Early Warning Score (MEWS) and Triage Early Warning Score (TREWS) to predict severity and mortality in hospitalized COVID-19 patients.
methodsIn this retrospective cohort study, patients hospitalized with COVID-19 at the Instituto de Infectologia Emílio Ribas (IIER) were included. MEWS and TREWS scores were calculated based on patients' vital signs at the time of admission to IIER.
resultsThe study included 579 patients, predominantly male (60.45%), with a mean age of 52.54 years. Comorbidities such as diabetes mellitus (23.32%) and systemic arterial hypertension (41.28%) were common. Most patients were not fully vaccinated against COVID-19 (65.46%). The estimated 14-day survival was 75.10% for patients with MEWS ≤ 3.5 at admission and 56.50% for those with MEWS > 3.5 at admission (p < 0.001). The 14-day survival for patients with a TREWS ≤ 7.5 was 78.00%, compared to 52.80% for those with a TREWS > 7.5 (p < 0.001). Each additional point in MEWS was associated with a 1.33-fold increase in the odds of ICU admission (p < 0.001) and 1.51-fold increase in the odds of death (p < 0.001). Each additional point in TREWS was associated with a 1.36-fold increase in ICU admission (p < 0.001) and 1.49-fold increase in death (p < 0.001).
conclusionsBoth scores demonstrated the ability to identify critically ill patients at the time of admission.
Indexed as
Identifiers
41217699What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.